Approvals/TGA/RISEDRONATE-WGR risedronate sodium (as hemipentahydrate) 35 mg tablet blister pack

Approved

STANDARD

RISEDRONATE-WGR risedronate sodium (as hemipentahydrate) 35 mg tablet blister pack

GM Pharma International Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: aa2403c4af115505
Product Name: RISEDRONATE-WGR risedronate sodium (as hemipentahydrate) 35 mg tablet blister pack
Artg Id: 160636
Artg Name: RISEDRONATE-WGR risedronate sodium (as hemipentahydrate) 35 mg tablet blister pack
Sponsor: GM Pharma International Pty Ltd
Company Detail Path: /organization/gm-pharma-international-pty-ltd
Artg Date: 2010-11-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/21ef8b738e52809d9183ffa034d03e68.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/d522bad9187991f6b7b54b75f917fc38.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

aa2403c4af115505

Type

Standard